Subtype
Intestinal Neuroendocrine Neoplasm
CI-CAN-00001025Explore in graph →
Non-malignant10 active trials
- NCIt
- C5695
Loading cancer entity…
Subtype
CI-CAN-00001025Explore in graph →
Clinical trials
19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07759960 | Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors | recruiting | N/A | 174 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06876532 | Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour(LUTIBI) | recruiting | N/A | 150 | Institut Claudius RegaudOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07612748 | Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms | recruiting | N/A | 483 | Jilin UniversityOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT06279299 |
Data updated 22 days agoSource updated Aug 12, 2026source: clinicaltrials
| Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision |
| recruiting |
| N/A |
| 30 |
| National Cancer Center, ChinaOTHER |
| 1 |
| Feb 28, 2024 |
| clinicaltrials |